NZX Governance Explorer

Ryman Healthcare Limited (RYM)

NZX-listed Healthcare company — share price, dividends, financials, board of directors and governance score.

Ryman Healthcare Limited (NZX:RYM) last traded at $1.96 on 25 Sept 2026, a market capitalisation of $2.08B NZD, a board of 13 directors chaired by Dean Ross Hamilton and a Governance Risk Score of 81/100.

Ryman Healthcare Limited is Australasia's largest developer and operator of retirement villages and aged care facilities, providing independent living, assisted living, and rest home care for seniors. Founded in Christchurch in 1984, Ryman has grown to operate over 45 villages across New Zealand and Australia, housing more than 14,000 residents. The company's integrated village model offers a continuum of care, allowing residents to age in place with access to increasing levels of support as needed. Ryman villages are known for their high-quality design, comprehensive amenities, and award-winning care services. Listed on the NZX and ASX, Ryman continues to expand its village network, with an active development pipeline in both countries. The company has consistently been recognised as one of New Zealand's most trusted brands in aged care.

Share price
$1.96-0.51%
Market cap
$2.08BNZD
Governance score
81/100Excellent
Board size
1392% independent
Last dividend
8.80cFY2023

Loading issuer details...

Ryman Healthcare Limited board of directors

13 current directors, 92% independent, average tenure 6.8 years.

DirectorRoleIndependentAppointedTenureCommittees
Paula JeffsIndependent DirectorYes20233.2 yrsAudit & Risk Committee (Chair)
Dean Ross HamiltonChairYes20241.8 yrsAudit & Risk Committee (Chair)
Kate MunningsIndependent DirectorYes20232.9 yrsAudit & Risk Committee (Chair)
Scott PritchardIndependent DirectorYes20241.9 yrsAudit & Risk Committee (Chair)
James MillerIndependent DirectorYes20233.2 yrsAudit & Risk Committee (Chair)
Warren James BellIndependent DirectorYes201115.7 yrs—
Joanne AppleyardIndependent DirectorYes200817.7 yrs—
George SavvidesIndependent DirectorYes201313.7 yrs—
David PitmanIndependent DirectorYes20242.4 yrsAudit & Risk Committee (Chair)
Hamish RumboldIndependent DirectorYes———
Anthony LeighsIndependent DirectorYes20188.7 yrsAudit & Risk Committee (Chair)
Geoffrey A CummingIndependent DirectorYes20188.3 yrs—
Naomi JamesExecutive DirectorNo20241.9 yrs—

RYM governance score breakdown

Ryman Healthcare Limited scores 81/100 (Excellent) on the NZXplorer Governance Risk Score for FY2026, based on 73% data coverage. See the GRS methodology.

Board structure
22/25
Shareholder rights
20/20
Executive remuneration
3/10

RYM dividends

The most recent Ryman Healthcare Limited dividend on record is 8.80 cents per share, for FY2023 (annual).

Ryman Healthcare Limited largest shareholders

Top 10 registered holders of RYM as disclosed for FY2024. Registry holdings include custodians and nominees, which may hold on behalf of many underlying investors.

#HolderHolding
1HSBC Nominees (New Zealand) Limited0.08%
2BNP Paribas Nominees (NZ) Limited0.08%
3Karori Capital Limited0.08%
4Custodial Services Limited0.06%
5Citibank Nominees (NZ) Ltd0.06%
6BNP Paribas Nominees NZ Limited Bpss400.06%
7Forsyth Barr Custodians Limited0.05%
8Hickman Family Trustees Limited0.05%
10JPMorgan Chase Bank0.04%
11BNP Paribas Nominees NZ Limited0.03%

Recent RYM NZX announcements

The 10 most recent filings by Ryman Healthcare Limited to the NZX.

Healthcare companies on the NZX

Compare Ryman Healthcare Limited with other NZX-listed healthcare companies.

All NZX Healthcare companies · All 131 NZX-listed companies